These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19293202)

  • 21. Outcome measures for COPD treatments: a critical evaluation.
    Gross NJ
    COPD; 2004 Apr; 1(1):41-57. PubMed ID: 16997738
    [No Abstract]   [Full Text] [Related]  

  • 22. Antioxidant enzymes and melatonin levels in patients with bronchial asthma and chronic obstructive pulmonary disease during stable and exacerbation periods.
    Gumral N; Naziroglu M; Ongel K; Beydilli ED; Ozguner F; Sutcu R; Caliskan S; Akkaya A
    Cell Biochem Funct; 2009 Jul; 27(5):276-83. PubMed ID: 19475625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantifying bronchodilator responses in chronic obstructive pulmonary disease trials.
    Lavorini F
    Br J Clin Pharmacol; 2005 Apr; 59(4):385-6. PubMed ID: 15801932
    [No Abstract]   [Full Text] [Related]  

  • 24. [Causes of death and risk factors for mortality in patients with severe chronic obstructive pulmonary disease].
    Moreno A; Montón C; Belmonte Y; Gallego M; Pomares X; Real J
    Arch Bronconeumol; 2009 Apr; 45(4):181-6. PubMed ID: 19328612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chronic obstructive pulmonary disease (COPD)].
    Escarrabill J
    An Med Interna; 2003 Jul; 20(7):337-9. PubMed ID: 12892549
    [No Abstract]   [Full Text] [Related]  

  • 26. Use of spirometry in the diagnosis of chronic obstructive pulmonary disease and efforts to improve quality of care.
    Joo MJ; Au DH; Lee TA
    Transl Res; 2009 Sep; 154(3):103-10. PubMed ID: 19665686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and pharmacoeconomic profile of COPD patients with FEV1 50--60% predicted: pilot study on the impact of the extended indication of ICS/LABA.
    Dal Negro RW; Bonadiman L; Turati C; Turco P
    Ther Adv Respir Dis; 2009 Apr; 3(2):51-8. PubMed ID: 19443518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of hospital admission for chronic obstructive pulmonary disease exacerbations in Canadian emergency departments.
    Rowe BH; Villa-Roel C; Guttman A; Ross S; Mackey D; Sivilotti ML; Worster A; Stiell IG; Willis V; Borgundvaag B
    Acad Emerg Med; 2009 Apr; 16(4):316-24. PubMed ID: 19298621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease.
    Lee TA; Schumock GT; Bartle B; Pickard AS
    Pharmacotherapy; 2009 Sep; 29(9):1039-53. PubMed ID: 19698009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolving concepts in the measurement of treatment effects.
    Leidy NK
    Proc Am Thorac Soc; 2006 May; 3(3):212-7. PubMed ID: 16636087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma.
    Fens N; Zwinderman AH; van der Schee MP; de Nijs SB; Dijkers E; Roldaan AC; Cheung D; Bel EH; Sterk PJ
    Am J Respir Crit Care Med; 2009 Dec; 180(11):1076-82. PubMed ID: 19713445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Measuring breathing pattern in patients with chronic obstructive pulmonary disease by electrical impedance tomography].
    Balleza M; Calaf N; Feixas T; González M; Antón D; Riu PJ; Casan P
    Arch Bronconeumol; 2009 Jul; 45(7):320-4. PubMed ID: 19497652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Health-care quality standards in chronic obstructive pulmonary disease].
    Soler-Cataluña JJ; Calle M; Cosío BG; Marín JM; Monsó E; Alfageme I; ;
    Arch Bronconeumol; 2009 Apr; 45(4):196-203. PubMed ID: 19304362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities.
    Miravitlles M; Soriano JB; García-Río F; Muñoz L; Duran-Tauleria E; Sanchez G; Sobradillo V; Ancochea J
    Thorax; 2009 Oct; 64(10):863-8. PubMed ID: 19553233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evidence and technique for exercise training in patients with COPD].
    Halle M; Heitmann RH; Kenn K; Petro W; Schultz K
    Pneumologie; 2008 Apr; 62(4):209-21; quiz 222-3. PubMed ID: 18393181
    [No Abstract]   [Full Text] [Related]  

  • 36. Patient-reported outcome (PRO) measures for clinical trials of COPD: the EXACT and E-RS.
    Leidy NK; Murray LT
    COPD; 2013 Jun; 10(3):393-8. PubMed ID: 23713600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of early inpatient rehabilitation after acute exacerbation of COPD.
    Clini EM; Crisafulli E; Costi S; Rossi G; Lorenzi C; Fabbri LM; Ambrosino N
    Respir Med; 2009 Oct; 103(10):1526-31. PubMed ID: 19447015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung volume reduction surgery for the management of refractory dyspnea in chronic obstructive pulmonary disease.
    Shah AA; D'Amico TA
    Curr Opin Support Palliat Care; 2009 Jun; 3(2):107-11. PubMed ID: 19436210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-management for breathlessness in COPD: the role of pulmonary rehabilitation.
    Gysels MH; Higginson IJ
    Chron Respir Dis; 2009; 6(3):133-40. PubMed ID: 19643827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An overview of acute exacerbations of COPD: assessing and preventing acute exacerbations of COPD.
    Kelly C
    Nurs Times; 2009 Apr 7-13; 105(13):25-6, 28. PubMed ID: 19405290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.